Drug Enforcement Administration May 2019 – Federal Register Recent Federal Regulation Documents

Importer of Controlled Substances Registration
Document Number: 2019-10669
Type: Notice
Date: 2019-05-22
Agency: Drug Enforcement Administration, Department of Justice
The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I and schedule II controlled substances.
Importer of Controlled Substances Application: United States Pharmacopeial Convention
Document Number: 2019-10668
Type: Notice
Date: 2019-05-22
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Wildlife Laboratories, Inc.
Document Number: 2019-10030
Type: Notice
Date: 2019-05-15
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Registration
Document Number: 2019-10028
Type: Notice
Date: 2019-05-15
Agency: Drug Enforcement Administration, Department of Justice
The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I and schedule II controlled substances.
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-10026
Type: Notice
Date: 2019-05-15
Agency: Drug Enforcement Administration, Department of Justice
The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of schedule I and II controlled substances.
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-10025
Type: Notice
Date: 2019-05-15
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule I controlled substances.
Fred J. Powell, M.D.; Decision and Order
Document Number: 2019-10019
Type: Notice
Date: 2019-05-15
Agency: Drug Enforcement Administration, Department of Justice
Raquel Skidmore, M.D.; Decision and Order
Document Number: 2019-10015
Type: Notice
Date: 2019-05-15
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2019-10014
Type: Notice
Date: 2019-05-15
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of schedule I and II controlled substances.
Bulk Manufacturer of Controlled Substances Application: AMPAC Fine Chemicals Virginia, LLC
Document Number: 2019-10013
Type: Notice
Date: 2019-05-15
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Rhodes Technologies
Document Number: 2019-10010
Type: Notice
Date: 2019-05-15
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: S & B Pharma, Inc
Document Number: 2019-10008
Type: Notice
Date: 2019-05-15
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: AndersonBrecon, Inc.
Document Number: 2019-10007
Type: Notice
Date: 2019-05-15
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: AndersonBrecon Inc. DBA PCI of Illinois
Document Number: 2019-10006
Type: Notice
Date: 2019-05-15
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl in Schedule I
Document Number: 2019-09479
Type: Rule
Date: 2019-05-08
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Drug Enforcement Administration places beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2- (thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide), also known as N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenyl- propanamide, including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. This rule continues the imposition of the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle beta-hydroxythiofentanyl.
Schedules of Controlled Substances: Placement of Furanyl Fentanyl, 4-Fluoroisobutyryl Fentanyl, Acryl Fentanyl, Tetrahydrofuranyl Fentanyl, and Ocfentanil in Schedule I; Correction
Document Number: 2019-09477
Type: Rule
Date: 2019-05-08
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration is correcting a final order that appeared in the Federal Register on November 29, 2018. The document issued an action maintaining the placement of furanyl fentanyl, 4-fluoroisobutyryl fentanyl, acryl fentanyl, tetrahydrofuranyl fentanyl, and ocfentanil, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. A drafting oversight in the amendatory instructions did not correctly update the prefatory language on isomers to reflect the change in the paragraph number for the designation of 3-methylthiofentanyl.
Schedules of Controlled Substances: Temporary Placement of N
Document Number: 2019-08704
Type: Proposed Rule
Date: 2019-05-01
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule the synthetic cathinones, N-ethylhexedrone; alpha- pyrrolidinohexanophenone (trivial name: [alpha]-PHP); 4-methyl-alpha- ethylaminopentiophenone (trivial name: 4-MEAP); 4'-methyl-alpha- pyrrolidinohexiophenone (trivial name: MPHP); alpha- pyrrolidinoheptaphenone (trivial name: PV8); and 4-chloro-alpha- pyrrolidinovalerophenone (trivial name: 4-chloro-[alpha]-PVP), in schedule I. When it is issued, the temporary scheduling order will impose regulatory requirements under the Controlled Substances Act (CSA) on the manufacture, distribution, reverse distribution, possession, importation, exportation, research, conduct of instructional activities, and chemical analysis of these synthetic cathinones, as well as administrative, civil, and criminal remedies with respect to persons who fail to comply with such requirements or otherwise violate the CSA with respect to these substances.